Menopause and Andropause
Female menopause has been recognized for centuries, but current research has elucidated a similar phenomenon in males—andropause—which is associated with analogous symptoms. Siemens Healthineers offers an extensive test menu for monitoring clinical indications of aging.
- Provides accurate results with sensitive assays to aid in the clinical diagnosis of various hormonal disorders.
- Reduces hands-on labor and improves workflow efficiency and turnaround time with fully automated assays.
Menopause, which, by definition, occurs one year after a woman's final menstrual cycle, is normally precipitated by the depletion of ovarian follicles due to aging, although it can also be induced by surgery (hysterectomy), radiation, chemotherapy and health problems.
During this time, hormone levels can fluctuate and change dramatically, causing various biochemical and physiological alterations. Proper measurement of steroid levels is invaluable in managing clinical conditions associated with aging.
Siemens Healthineers Assays for the Evaluation of Menopause*
In contrast to menopause, a clearly defined event for women, aging of the male endocrine system, beginning in middle-aged or elderly men, is a less abrupt, less clearly demarcated and highly variable process.
The free androgen index (FAI), cFT and other measures of free and bioavailable testosterone provide important alternatives to reliance on a Total testosterone measurement alone. They are useful in various clinical contexts including:
• Male androgen deprivation therapy
• Aging males
• Adrenal disorders
• Hirsutism and virilization
Percentage of healthy men with testosterone, FAI and cFT values lower than the 2.5th percentile of the 21–30 year age group.
Siemens Healthineers Assays for the Evaluation of Andropause*
*Product availability may vary from country to country and is subject to varying regulatory requirements. Not all assays are available on all instruments.
†Under development. Not available for sale.